New Stock News | Shenqi Pharmaceutical Submitted Documents to Hong Kong Stock Exchange, A Leader in Commercialization of China's Central Nervous System Specialty Drugs.

According to the financial news app APP, it was learned that on June 25, the Hong Kong Stock Exchange disclosed that Shenji Pharmaceutical Co., Ltd. (referred to as Shenji Pharmaceutical) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with JPMorgan Chase, CITIC Securities, and HSBC as its joint sponsors.